Greenwich LifeSciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 352.19 K | $3.36 M | -1.58% | 2.71% |
VANGUARD GROUP INC | 05/09/2025 | 270.31 K | $2.58 M | -1.70% | 2.08% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 137.01 K | $1.31 M | 2.19% | 1.05% |
CREDIT AGRICOLE S A | 05/14/2025 | 87.00 K | $829.98 K | 0.00% | 0.67% |
NORTHERN TRUST CORP | 05/13/2025 | 84.63 K | $807.40 K | -3.19% | 0.65% |
STATE STREET CORP | 05/15/2025 | 75.21 K | $717.48 K | 2.73% | 0.58% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 19.01 K | $181.33 K | 15.51% | 0.15% |
STRS OHIO | 05/28/2025 | 18.60 K | $177.44 K | 0.00% | 0.14% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 15.41 K | $146.98 K | 100.00% | 0.12% |
CITADEL ADVISORS LLC | 05/15/2025 | 13.31 K | $127.02 K | 100.00% | 0.10% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 12.50 K | $119.25 K | -44.93% | 0.10% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 11.20 K | $106.88 K | 0.00% | 0.09% |
RHUMBLINE ADVISERS | 05/29/2025 | 9.67 K | $92.27 K | 48.70% | 0.07% |
MORGAN STANLEY | 05/15/2025 | 9.55 K | $91.08 K | -30.69% | 0.07% |
BARCLAYS PLC | 05/15/2025 | 6.63 K | $64.00 K | -31.25% | 0.05% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 6.00 K | $57.00 K | 0.00% | 0.05% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.36 K | $51.15 K | -26.16% | 0.04% |
CITIGROUP INC | 05/12/2025 | 4.34 K | $41.39 K | -11.07% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 3.64 K | $34.71 K | 4.48% | 0.03% |
UBS GROUP AG | 05/13/2025 | 3.20 K | $30.49 K | -51.26% | 0.02% |
JPMORGAN CHASE & CO | 05/12/2025 | 3.06 K | $29.15 K | -56.73% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 2.99 K | $28.48 K | -1.45% | 0.02% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 2.91 K | $27.77 K | 2.25% | 0.02% |
ROYAL BANK OF CANADA | 05/15/2025 | 1.73 K | $16.00 K | 177.00% | 0.01% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/15/2025 | 1.30 K | $12.40 K | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.01 K | $9.61 K | -3.91% | 0.01% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 662 | $6.32 K | 0.00% | 0.01% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 585 | $5.58 K | 0.00% | 0.00% |
FOUNDERS CAPITAL MANAGEMENT | 04/08/2025 | 500 | $4.77 K | 0.00% | 0.00% |
FMR LLC | 05/12/2025 | 463 | $4.42 K | 240.44% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 433 | $4.13 K | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 424 | $4.05 K | -60.59% | 0.00% |
AMALGAMATED BANK | 04/25/2025 | 207 | $2.00 K | 0.00% | 0.00% |
WASHINGTON TRUST ADVISORS, INC. | 04/25/2025 | 200 | $1.91 K | 0.00% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 168 | $1.60 K | 100.00% | 0.00% |
GAMMA INVESTING LLC | 04/15/2025 | 126 | $1.20 K | 100.00% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 100 | $954 | 0.00% | 0.00% |
GENEOS WEALTH MANAGEMENT INC. | 05/21/2025 | 88 | $840 | 0.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 04/30/2025 | 65 | $620 | 100.00% | 0.00% |
NORTH STAR INVESTMENT MANAGEMENT CORP. | 04/17/2025 | 51 | $487 | 0.00% | 0.00% |
05/08/2025 | 50 | $477 | 0.00% | 0.00% | |
05/02/2025 | 30 | $286 | 0.00% | 0.00% | |
STERLING CAPITAL MANAGEMENT LLC | 05/13/2025 | 6 | $57 | 0.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 05/13/2025 | 3 | $29 | 100.00% | 0.00% |
TRUE WEALTH DESIGN, LLC | 05/13/2025 | 2 | $20 | 100.00% | 0.00% |
BROWN BROTHERS HARRIMAN & CO | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 0 | $0 | -100.00% | 0.00% |
Greenwich LifeSciences, Inc. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of Greenwich LifeSciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 352,191
VANGUARD GROUP INC: 270,306
GEODE CAPITAL MANAGEMENT, LLC: 137,010
CREDIT AGRICOLE S A: 87,000
NORTHERN TRUST CORP: 84,633
STATE STREET CORP: 75,208
8.93% of Greenwich LifeSciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.47 M shares in the last 24 months. This purchase volume represents approximately $14.18 M in transactions.